Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

8.92
Delayed Data
As of May 27
 +0.16 / +1.83%
Today’s Change
6.17
Today|||52-Week Range
22.66
-28.01%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close8.76
Today’s open8.87
Day’s range8.69 - 9.06
Volume48,041
Average volume (3 months)136,728
Market cap$262.5M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)+35.31%
Earnings growth (this year)-14.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.49

Competitors

 Today’s
change
Today’s
% change
INNLInnocoll Holdings PL...-0.02-0.19%
ARLZAralez Pharmaceutica...0.000.00%
VTLVital Therapies Inc+0.20+2.47%
SRNESorrento Therapeutic...+0.29+4.56%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)-$0.82
Annual revenue (last year)$0.00
Annual profit (last year)-$82.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers

Search for Jobs